Clinical Characteristics and Outcomes of 187 Critically Ill Patients With Coronavirus Disease 2019 (COVID-19)

CompletedOBSERVATIONAL
Enrollment

187

Participants

Timeline

Start Date

July 15, 2020

Primary Completion Date

September 20, 2020

Study Completion Date

November 30, 2020

Conditions
COVID-19
Interventions
OTHER

demographic and clinical data obtained from hospital's electronic medical record.

This retrospective observational study. . Demographic and severity data will include age, sex, SAPS 3 and SOFA scores at admission, nutritional risk determined by NRS-2002 and commodities. Clinical and laboratory data on arrival at the ICU including PaO2 / FIO2, blood count and PCR D-dimer, ferritin, fibrinogen, DHL. Drug interventions including use of hydroxychloroquine, corticosteroids, heparin, tocilizumab. Characteristics of invasive and non-invasive respiratory support, use of prone position and ECMO and vasoactive drugs. The main complications, acute kidney injury requiring renal replacement therapy, secondary infectious complications will be documented as well as the outcomes.

Trial Locations (1)

65060-000

Hospital Sao Domingos, São Luís

All Listed Sponsors
lead

Hospital Sao Domingos

OTHER

NCT04454372 - Clinical Characteristics and Outcomes of 187 Critically Ill Patients With Coronavirus Disease 2019 (COVID-19) | Biotech Hunter | Biotech Hunter